D-003.
D002986:Clinical Trials as Topic; D005227:Fatty Acids / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity
C418063:D-003 sugarcane wax acid mixture; D005227:Fatty Acids; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors